Related Experiment Videos
Self antigen prognostic for human immunodeficiency virus disease progression
C L Bristow1, H Patel, R R Arnold
1Department of Pathology and Laboratory Medicine, University of North Carolina-Chapel Hill, Chapel Hill, NC 27514, USA. bristoc@mail.rockefeller.edu
Clinical and Diagnostic Laboratory Immunology
|August 31, 2001
Summary
Alpha-1 proteinase inhibitor (alpha-1 PI) deficiency is common in HIV patients and linked to lower viral load. Addressing this deficiency may be key to managing HIV disease progression and related complications.
Area of Science:
- Immunology
- Virology
- Pulmonology
Background:
- Extracellular protein alpha-1 proteinase inhibitor (alpha(1)PI), also known as alpha(1) antitrypsin, plays a role in human immunodeficiency virus (HIV) infectivity.
- Alpha-1 PI deficiency is a known risk factor for degenerative lung diseases and reduced lifespan.
Purpose of the Study:
- To investigate the correlation between circulating alpha(1)PI levels and viral load in HIV-seropositive patients.
- To determine the prevalence of alpha(1)PI deficiency in different stages of HIV disease.
- To explore the relationship between HIV-associated alpha(1)PI deficiency and anti-alpha(1)PI immunoglobulin G.
Main Methods:
- Analysis of circulating alpha(1)PI levels in HIV-seropositive patients.
- Correlation analysis between alpha(1)PI levels and viral load.
- Assessment of anti-alpha(1)PI immunoglobulin G levels.
Main Results:
- Decreased viral load in HIV patients is significantly correlated with decreased circulating alpha(1)PI.
- 100% of asymptomatic HIV patients exhibit deficient levels of active alpha(1)PI.
- HIV-associated alpha(1)PI deficiency is correlated with the presence of circulating anti-alpha(1)PI immunoglobulin G.
Conclusions:
- Alpha-1 PI deficiency is a significant finding in HIV-seropositive individuals, even in asymptomatic stages.
- Preventing or treating HIV-associated alpha(1)PI deficiency may represent a novel therapeutic strategy for mitigating HIV pathophysiology.
- Further research is warranted to explore the clinical implications of alpha(1)PI deficiency in HIV management.